Updates in the Treatment of Spasticity Associated With Cerebral
Palsy. Summary of "Updates in the Treatment of Spasticity
Associated With Cerebral Palsy." Spasticity affects up to 80 %
of patients with cerebral palsy (CP) and often plays a
significant role in limiting the child's ability to function and
participate in daily activities. The treatment of spasticity
involves a multifaceted approach that includes pharmacological
treatment with antispasmodics, physical therapy to maintain
range of motion and prevent contractures, as well as a variety
of orthopedic and neurosurgical interventions. Pharmacological
agents currently used in clinical practice to treat spasticity
in children have existed for almost two decades and continue to
be used despite lack of solid evidence for their efficacy.
Studies detailing safety profiles and optimal dosing in the
pediatric population are greatly warranted. Intramuscular
injection of botulinum neurotoxin is becoming increasingly
popular for the treatment of segmental spastic